The Curies’ element: state of the art and perspectives on the use of radium in nuclear medicine
Abstract Background The alpha-emitter radium-223 (223Ra) is presently used in nuclear medicine for the palliative treatment of bone metastases from castration-resistant prostate cancer. This application arises from its advantageous decay properties and its intrinsic ability to accumulate in regions...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SpringerOpen
2023-11-01
|
| Serie: | EJNMMI Radiopharmacy and Chemistry |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s41181-023-00220-4 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
